Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
PDF) Evaluation of the abuse potential of difelikefalin, a selective kappa‐ opioid receptor agonist, in recreational polydrug users
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus | NEJM
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects
Experimental Kappa Opioid Appears Safe and Effective
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression<b>:</b> A randomized,
A New Path to Pain Relief: Time for a Change with a Peripherally Acting Kappa Opioid Receptor Agonist (KORA)Friday, March 17, 201712:30 PM – 1:30 PMGrand Caribbean Ballroom 7Loews Sapphire Falls ResortOrlando, Florida Survey
Cara Therapeutics: Developing Novel Peripheral Kappa Opioid Product Candidates
Difelikefalin: First Approval
EX-99.2
Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice | bioRxiv
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics
Cara Therapeutics - Invest In Weed
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
PDF) Effect of Difelikefalin, a Selective Kappa Opioid Receptor Agonist, on Respiratory Depression: A Randomized, Double‐Blind, Placebo‐Controlled Trial
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
κ-opioid receptor - Wikipedia
PDF) Purification of a kappa-opioid receptor subtype from frog brain | Mária Szücs, Anna Borsodi, and Kálmán Medzihradszky - Academia.edu
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
CR845 (Difelikefalin), A Kappa Receptors Agonist In Phase III By CARA Therapeutics: A Case Of 'Spin' In Scientific Writing? | Semantic Scholar
